Javascript must be enabled to continue!
Characterization and regulation of alpha-synuclein phosphorylation in enteric neurons under physiological conditions
View through CrossRef
Alpha-synuclein is a 140 aa neuronal protein pathologically and
genetically linked to Parkinson’s disease (PD). In PD, the major protein
modification of alpha-synuclein is phosphorylation at serine 129.
Alpha-synuclein is also phosphorylated at low levels under physiological
conditions but its regulation and role are still largely unknown.
Mounting evidence suggests a role for the gut-brain axis in CNS
homeostasis, and therefore we set out to examine the regulation of
alpha-synuclein phosphorylation in enteric neurons under physiological
conditions. To this end, primary cultures of rat enteric nervous system
(ENS) and enteric neurons, which both express alpha-synuclein, were
either depolarized or treated with forskolin and analyzed by western
blot. We found that membrane depolarization and forskolin induced
alpha-synuclein phosphorylation via a Ca2+-calmodulin-dependent protein
kinases and cAMP/exchange protein directly activated by cyclic AMP
(EPAC) signaling pathway, respectively. Both pathways converged on
Polo-like kinase 2 (PLK2) to phosphorylate alpha-synuclein. PLK 2
inhibition increased the amount of alpha-synuclein secretion while
reducing its intracellular phosphorylation level in both cytoplasmic and
membranous fraction. To investigate alpha-synuclein phosphorylation in
the ENS further, specimens of human colon were analyzed to show that the
distribution of phosphorylated alpha-synuclein in the ENS was highly
variable and that the amount of soluble phosphorylated alpha-synuclein
did not differ between PD and controls subjects. Our study is the first
to show that alpha-synuclein phosphorylation can be physiologically
regulated in enteric neurons, providing a basis to unravel the
physiological functions of alpha-synuclein and its phosphorylation in
the ENS.
Title: Characterization and regulation of alpha-synuclein phosphorylation in enteric neurons under physiological conditions
Description:
Alpha-synuclein is a 140 aa neuronal protein pathologically and
genetically linked to Parkinson’s disease (PD).
In PD, the major protein
modification of alpha-synuclein is phosphorylation at serine 129.
Alpha-synuclein is also phosphorylated at low levels under physiological
conditions but its regulation and role are still largely unknown.
Mounting evidence suggests a role for the gut-brain axis in CNS
homeostasis, and therefore we set out to examine the regulation of
alpha-synuclein phosphorylation in enteric neurons under physiological
conditions.
To this end, primary cultures of rat enteric nervous system
(ENS) and enteric neurons, which both express alpha-synuclein, were
either depolarized or treated with forskolin and analyzed by western
blot.
We found that membrane depolarization and forskolin induced
alpha-synuclein phosphorylation via a Ca2+-calmodulin-dependent protein
kinases and cAMP/exchange protein directly activated by cyclic AMP
(EPAC) signaling pathway, respectively.
Both pathways converged on
Polo-like kinase 2 (PLK2) to phosphorylate alpha-synuclein.
PLK 2
inhibition increased the amount of alpha-synuclein secretion while
reducing its intracellular phosphorylation level in both cytoplasmic and
membranous fraction.
To investigate alpha-synuclein phosphorylation in
the ENS further, specimens of human colon were analyzed to show that the
distribution of phosphorylated alpha-synuclein in the ENS was highly
variable and that the amount of soluble phosphorylated alpha-synuclein
did not differ between PD and controls subjects.
Our study is the first
to show that alpha-synuclein phosphorylation can be physiologically
regulated in enteric neurons, providing a basis to unravel the
physiological functions of alpha-synuclein and its phosphorylation in
the ENS.
Related Results
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">ΠΗΛΙΝΑ ΙΓ&Delta...
Characterization and Regulation of Alpha‐Synuclein Phosphorylation in Enteric Neurons
Characterization and Regulation of Alpha‐Synuclein Phosphorylation in Enteric Neurons
ABSTRACT
Alpha‐synuclein is a 140 aa neuronal protein pathologically and genetically linked to Parkinson's disease (PD). In PD, the major pro...
Un manoscritto equivocato del copista santo Theophilos († 1548)
Un manoscritto equivocato del copista santo Theophilos († 1548)
<p><font size="3"><span class="A1"><span style="font-family: 'Times New Roman','serif'">ΕΝΑ ΛΑΝ&...
Comparison of commercially available antibodies for the detection of phosphorylated alpha‐synuclein in primary culture of ENS
Comparison of commercially available antibodies for the detection of phosphorylated alpha‐synuclein in primary culture of ENS
Abstract
Background
It is now well established that phosphorylated alpha‐synuclein histopathology, the pathologic hallmar...
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
AbstractBackgroundNNI‐362 is a novel small molecule identified by phenotypic screening to discover compounds that promote new neurons from human neural progenitor cells and have ne...
Acute inflammation down‐regulates alpha‐synuclein expression in enteric neurons
Acute inflammation down‐regulates alpha‐synuclein expression in enteric neurons
AbstractThe protein alpha‐synuclein whose expression is strongly implicated in Parkinson's disease (PD) is not only expressed in the CNS but also in the enteric nervous system (ENS...
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
Animal models of Parkinson’s disease, in which the human α-synuclein transgene is overexpressed in the nigrostriatal pathway using viral vectors, are widely considered to be the mo...

